Novel Influenza Virus NS1 Antagonists Block Replication and Restore Innate Immune Function

ABSTRACT The innate immune system guards against virus infection through a variety of mechanisms including mobilization of the host interferon system, which attacks viral products mainly at a posttranscriptional level. The influenza virus NS1 protein is a multifunctional facilitator of virus replication, one of whose actions is to antagonize the interferon response. Since NS1 is required for efficient virus replication, it was reasoned that chemical inhibitors of this protein could be used to further understand virus-host interactions and also serve as potential new antiviral agents. A yeast-based assay was developed to identify compounds that phenotypically suppress NS1 function. Several such compounds exhibited significant activity specifically against influenza A virus in cell culture but had no effect on the replication of another RNA virus, respiratory syncytial virus. Interestingly, cells lacking an interferon response were drug resistant, suggesting that the compounds block interactions between NS1 and the interferon system. Accordingly, the compounds reversed the inhibition of beta interferon mRNA induction during infection, which is known to be caused by NS1. In addition, the compounds blocked the ability of NS1 protein to inhibit double-stranded RNA-dependent activation of a transfected beta interferon promoter construct. The effects of the compounds were specific to NS1, because they had no effect on the ability of the severe acute respiratory syndrome coronavirus papainlike protease protein to block beta interferon promoter activation. These data demonstrate that the function of NS1 can be modulated by chemical inhibitors and that such inhibitors will be useful as probes of biological function and as starting points for clinical drug development.

[1]  P. Palese,et al.  Influenza: old and new threats , 2004, Nature Medicine.

[2]  G. Fink,et al.  Methods in yeast genetics , 1979 .

[3]  F. Hayden,et al.  Antiviral management of seasonal and pandemic influenza. , 2006, The Journal of infectious diseases.

[4]  J. Taubenberger,et al.  The 1918 Spanish influenza: integrating history and biology. , 2001, Microbes and infection.

[5]  R. Lamb,et al.  A new influenza virus virulence determinant: The NS1 protein four C-terminal residues modulate pathogenicity , 2008, Proceedings of the National Academy of Sciences.

[6]  A. Osterhaus,et al.  Global Patterns of Influenza A Virus in Wild Birds , 2006, Science.

[7]  C. Basler,et al.  Progress in identifying virulence determinants of the 1918 H1N1 and the Southeast Asian H5N1 influenza A viruses. , 2008, Antiviral research.

[8]  J. Melnick,et al.  Defectiveness of Interferon Production and of Rubella Virus Interference in a Line of African Green Monkey Kidney Cells (Vero) , 1968, Journal of virology.

[9]  Zhongbin Chen,et al.  Regulation of IRF-3-dependent Innate Immunity by the Papain-like Protease Domain of the Severe Acute Respiratory Syndrome Coronavirus , 2007, Journal of Biological Chemistry.

[10]  K. Nichol,et al.  Vaccines for seasonal and pandemic influenza. , 2006, The Journal of infectious diseases.

[11]  F. Hayden,et al.  Antivirals for influenza: historical perspectives and lessons learned. , 2006, Antiviral research.

[12]  A. García-Sastre,et al.  A Recombinant Influenza A Virus Expressing anRNA-Binding-Defective NS1 Protein Induces High Levels of BetaInterferon and Is Attenuated inMice , 2003, Journal of Virology.

[13]  Thorsten Wolff,et al.  The Influenza A Virus NS1 Protein Inhibits Activation of Jun N-Terminal Kinase and AP-1 Transcription Factors , 2002, Journal of Virology.

[14]  R. Krug,et al.  Cellular antiviral responses against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 3' end processing of cellular pre-mRNAS. , 2003, Virology.

[15]  G. Kochs,et al.  Properties of H7N7 influenza A virus strain SC35M lacking interferon antagonist NS1 in mice and chickens. , 2007, The Journal of general virology.

[16]  C. Boschek,et al.  Isolation and properties of a temperature-sensitive mutant (ts 412) of an influenza A virus recombinant with a ts lesion in the gene coding for the nonstructural protein. , 1981, Virology.

[17]  D. Somer,et al.  Regulation of the Interferon System : Evidence that Vero Cells have a Genetic Defect in Interferon Production , 2007 .

[18]  R. Krug,et al.  The influenza virus NS1 protein is a poly(A)-binding protein that inhibits nuclear export of mRNAs containing poly(A) , 1994, Journal of virology.

[19]  A Flahault,et al.  Influenza vaccine: the challenge of antigenic drift. , 2007, Vaccine.

[20]  C. Scholtissek,et al.  A mutant of fowl plague virus (influenza A) with an enhanced electrophoretic mobility of RNA segment 8. , 1985, The Journal of general virology.

[21]  T. Fujita,et al.  NS1 protein of influenza A virus inhibits the function of intracytoplasmic pathogen sensor, RIG-I. , 2007, American journal of respiratory cell and molecular biology.

[22]  I. Macreadie,et al.  Expression and characterisation of the influenza A virus non-structural protein NS1 in yeast , 1994, Archives of Virology.

[23]  R. M. Marión,et al.  Influenza virus NS1 protein interacts with viral transcription-replication complexes in vivo. , 1997, The Journal of general virology.

[24]  David E. Levy,et al.  Influenza virus targets the mRNA export machinery and the nuclear pore complex , 2007, Proceedings of the National Academy of Sciences.

[25]  J. Taubenberger,et al.  Integrating historical, clinical and molecular genetic data in order to explain the origin and virulence of the 1918 Spanish influenza virus. , 2001, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[26]  A. García-Sastre,et al.  Attenuation and immunogenicity in mice of temperature-sensitive influenza viruses expressing truncated NS1 proteins. , 2005, The Journal of general virology.

[27]  M. Katze,et al.  Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the elF-2 translation initiation factor. , 1995, Virology.

[28]  A. Pichlmair,et al.  RIG-I-Mediated Antiviral Responses to Single-Stranded RNA Bearing 5'-Phosphates , 2006, Science.

[29]  J. Ortín,et al.  Genetic Analysis of Influenza Virus NS1 Gene: a Temperature-Sensitive Mutant Shows Defective Formation of Virus Particles , 2005, Journal of Virology.

[30]  Wang Guansong,et al.  Update on avian influenza A (H5N1) virus infection in humans , 2009 .

[31]  R. Chanock,et al.  Temperature-sensitive mutants of influenza A/Udorn/72 (H3N2) virus. I. Isolation of temperature-sensitive mutants some of which exhibit host-dependent temperature sensitivity. , 1982, Virology.

[32]  K. Shimizu,et al.  Analysis of influenza A virus temperature-sensitive mutants with mutations in RNA segment 8. , 1990, The Journal of general virology.

[33]  Shou-Wei Ding,et al.  Interferon antagonist proteins of influenza and vaccinia viruses are suppressors of RNA silencing. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[34]  G T Montelione,et al.  An amino-terminal polypeptide fragment of the influenza virus NS1 protein possesses specific RNA-binding activity and largely helical backbone structure. , 1995, RNA.

[35]  R. Krug,et al.  U 6 atac snRNA , the highly divergent counterpart of U 6 snRNA , is the specific target that mediates inhibition of ATAC splicing by the influenza virus NS 1 protein , 1998 .

[36]  Richard B. Brown,et al.  Complications of Viral Influenza , 2008, The American Journal of Medicine.

[37]  R. Krug,et al.  The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: Inhibiting the 2'-5' oligo (A) synthetase/RNase L pathway. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[38]  S. Ludwig,et al.  Amino acid replacements leading to temperature-sensitive defects of the NS1 protein of influenza A virus , 2005, Archives of Virology.

[39]  David E. Swayne,et al.  Sequence of the 1918 pandemic influenza virus nonstructural gene (NS) segment and characterization of recombinant viruses bearing the 1918 NS genes , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[40]  R. Krug,et al.  U6atac snRNA, the highly divergent counterpart of U6 snRNA, is the specific target that mediates inhibition of AT-AC splicing by the influenza virus NS1 protein. , 1998, RNA.

[41]  Gabriele Neumann,et al.  Human infection with highly pathogenic H5N1 influenza virus , 2008, The Lancet.

[42]  A. Goffeau,et al.  The pleitropic drug ABC transporters from Saccharomyces cerevisiae. , 2001, Journal of molecular microbiology and biotechnology.

[43]  M. Zambon,et al.  Confronting the avian influenza threat: vaccine development for a potential pandemic , 2004, The Lancet Infectious Diseases.

[44]  A. Fernández-Sesma.  The influenza virus NS1 protein: inhibitor of innate and adaptive immunity. , 2007, Infectious disorders drug targets.

[45]  G. Montelione,et al.  RNA binding by the novel helical domain of the influenza virus NS1 protein requires its dimer structure and a small number of specific basic amino acids. , 1999, RNA.

[46]  E. Bucher,et al.  The influenza A virus NS1 protein binds small interfering RNAs and suppresses RNA silencing in plants. , 2004, The Journal of general virology.

[47]  L. Reed,et al.  A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS , 1938 .

[48]  W. Thompson,et al.  Epidemiology of seasonal influenza: use of surveillance data and statistical models to estimate the burden of disease. , 2006, The Journal of infectious diseases.

[49]  R. Chanock,et al.  Temperature-sensitive mutants of influenza A/Udorn/72 (H3N2) virus. III. Genetic analysis of temperature-dependent host range mutants. , 1983, Virology.

[50]  A. Wolstenholme,et al.  Influenza virus-specific RNA and protein syntheses in cells infected with temperature-sensitive mutants defective in the genome segment encoding nonstructural proteins , 1980, Journal of virology.

[51]  Helen M. Berman,et al.  Crystal structure of the unique RNA-binding domain of the influenza virus NS1 protein , 1997, Nature Structural Biology.

[52]  Michael Gale,et al.  Inhibition of Retinoic Acid-Inducible Gene I-Mediated Induction of Beta Interferon by the NS1 Protein of Influenza A Virus , 2006, Journal of Virology.

[53]  R. Fukuda,et al.  Binding of influenza A virus NS1 protein to dsRNA in vitro. , 1992, The Journal of general virology.

[54]  R. Krug,et al.  Intracellular warfare between human influenza viruses and human cells: the roles of the viral NS1 protein. , 2003, Virology.

[55]  J. Gog,et al.  Codon conservation in the influenza A virus genome defines RNA packaging signals , 2007, Nucleic acids research.

[56]  J. Ortín,et al.  Development of an HTS Assay for the Search of Anti-influenza Agents Targeting the Interaction of Viral RNA with the NS1 Protein , 2008, Journal of biomolecular screening.

[57]  J. McKimm-Breschkin,et al.  Conditions required for induction of interferon by rotaviruses and for their sensitivity to its action , 1982, Infection and Immunity.

[58]  G. Kochs,et al.  Multiple Anti-Interferon Actions of the Influenza A Virus NS1 Protein , 2007, Journal of Virology.

[59]  R. Krug,et al.  Two functional domains of the influenza virus NS1 protein are required for regulation of nuclear export of mRNA , 1994, Journal of virology.

[60]  R. Fukuda,et al.  Binding of the influenza virus NS1 protein to model genome RNAs. , 1997, The Journal of general virology.

[61]  Amer A. Beg,et al.  Influenza A Virus NS1 Protein Prevents Activation of NF-κB and Induction of Alpha/Beta Interferon , 2000, Journal of Virology.

[62]  H. Katinger,et al.  Transfectant Influenza A Viruses with Long Deletions in the NS1 Protein Grow Efficiently in Vero Cells , 1998, Journal of Virology.

[63]  A. Monto,et al.  Seasonal and pandemic influenza: a 2007 update on challenges and solutions. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[64]  E. Nishida,et al.  Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF‐3 and CBP/p300 , 1998, The EMBO journal.

[65]  M. Shaw,et al.  Immunologic studies on the influenza A virus nonstructural protein NS1 , 1982, The Journal of experimental medicine.

[66]  A. García-Sastre,et al.  Activation of Interferon Regulatory Factor 3 Is Inhibited by the Influenza A Virus NS1 Protein , 2000, Journal of Virology.

[67]  A. Beloso,et al.  Influenza virus NS1 protein inhibits pre‐mRNA splicing and blocks mRNA nucleocytoplasmic transport. , 1994, The EMBO journal.

[68]  R. Fukuda,et al.  Specific binding of influenza A virus NS1 protein to the virus minus-sense RNA in vitro. , 1992, The Journal of general virology.

[69]  R. Krug,et al.  Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3'end formation of cellular pre-mRNAs. , 1998, Molecular cell.

[70]  A. Oomens,et al.  Infectivity of a Human Respiratory Syncytial Virus Lacking the SH, G, and F Proteins Is Efficiently Mediated by the Vesicular Stomatitis Virus G Protein , 2003, Journal of Virology.

[71]  R. Krug,et al.  A site on the influenza A virus NS1 protein mediates both inhibition of PKR activation and temporal regulation of viral RNA synthesis. , 2007, Virology.

[72]  R. Krug,et al.  Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double-stranded RNA. , 2006, Virology.

[73]  J. Bartlett,et al.  Seasonal and pandemic influenza: recommendations for preparedness in the United States. , 2006, Journal of Infectious Diseases.

[74]  D. Levy,et al.  Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. , 1998, Virology.

[75]  R. Krug,et al.  The influenza virus NS1 protein binds to a specific region in human U6 snRNA and inhibits U6-U2 and U6-U4 snRNA interactions during splicing. , 1995, RNA.

[76]  A. García-Sastre,et al.  Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach. , 2000, Proceedings of the National Academy of Sciences of the United States of America.